Drugs Made In America Acquisition Corp. (DMAAR) Long-Term Debt Issuances (2025)

Drugs Made In America Acquisition (DMAAR) has reported Long-Term Debt Issuances for 1 consecutive years, with $900000.0 the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $900000.0; the trailing twelve-month figure through Dec 2025 stood at $900000.0 (changed N/A YoY), and the FY2025 full-year result was $900000.0, down 50.07% from the prior year.
• Long-Term Debt Issuances steadied at $900000.0 in Q1 2025 per DMAAR's latest filing.
• Across five years, Long-Term Debt Issuances topped out at $900000.0 in Q1 2025 and bottomed at $900000.0 in Q1 2025.